DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20194279

Comparative clinical study of efficacy and safety of adapalene 0.1% gel versus benzoyl peroxide 2.5% gel for the treatment of acne vulgaris

Anuradha Dubey, Hanmant Amane

Abstract


Background: Acne vulgaris is characterised by comedones, papules, pustules and nodules occurring in a sebaceous distribution. Topical treatments, such as adapalene and benzoyl peroxide, are popular in mild to moderate acne vulgaris. This study was aimed to compare the efficacy and safety of adapalene with benzoyl peroxide in the patients of mild to moderate acne vulgaris.

Methods: We planned a randomized, open-labelled, prospective study to compare the efficacy and side effects of adapalene and benzoyl peroxide in acne patients. A total of 100 patients with mild to moderate acne vulgaris were included in the study. They were randomly divided into 2 groups with 50 patients in each group. One group was given 0.1% adapalene gel and the other group received 2.5% benzoyl peroxide gel. Efficacy was assessed as reduction in the lesion counts, whereas for safety, the side effects like dryness, burning, irritation, erythema were recorded during the treatment. Total duration of the study was 3 months.

Results: The study revealed that adapalene was more effective than benzoyl peroxide in treating non-inflammatory and inflammatory lesions of acne vulgaris, and there was a statistically significant difference found between the groups (p≤0.05) in efficacy. Adapalene was also found to be comparatively safer than benzoyl peroxide because the patients treated with adapalene had lesser side effects than those treated with benzoyl peroxide.

Conclusions: Our study concludes a better efficacy and safety of adapalene than benzoyl peroxide in the treatment of mild to moderate acne vulgaris.


Keywords


Acne, Lesion counts, Retinoids, Topical treatment

Full Text:

PDF

References


Kawashima M, Nagare T, Masaharu DOI. Clinical efficacy and safety of benzoyl peroxide for acne vulgaris: comparison between Japanese and Western patients. J Dermatol. 2017;44:1-7.

Gowda A, Sanmitha SK, Satish KS. Comparative study of clinical efficacy and side effects of adapalene 0.1% gel and benzoyl peroxide 2.5% gel as monotherapies and combination therapy in facial acne: Indian prospective. J Evol Med Dent Sci. 2014;3:3786-98.

Babaeinejad SH, Fouladi RF. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a Randomized trial. J Drug Dermatol. 2013;12:1033-8.

Czernielewski J, Michel S, Bouclier M, Baker M, Hensby JC. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol. 2001;15:5-12.

Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintainance treatment with adapalene gel, 0.1%. J Eur Acad Dermatol Venereol. 2007;21:747-53.

Gupta AK, Lynde CW, Kunynetz RA, Amin S, Choi K, Goldstein E. A randomized, double-blind, multicentre, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/ 5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. J Cutan Med Surg. 2003;7:31-7.

Mills OH, Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1986;25:664-7.

do Nascimento LV, Guedes AC, Magalhaes GM, de Faria FA, Guerra RM, de C Almeida F. Single-blind and comparative clinical study of the efficacy and safety of benzoyl peroxide 4% gel (BD) and adapalene 0.1% gel (QID) in the treatment of acne vulgaris for 11 weeks. J Dermatol Treat. 2003;14:166-71.

Korkut C, Piskin S. Benzoyl peroxide, adapalene and their combination in the treatment of acne vulgaris. J Dermatol. 2005;32:169-73.

Rathi SK. Acne vulgaris treatment: the current scenario. Indian J Dermatol. 2011;56:7-13.

Christophers E, Wolfe HH. Effect of Vitamin A acid on skin; in vitro and in vivo studies. Acta Derm Venereol (Stockh). 1975;74:42-53.

Shalita A, Weiss J, Chalker D, Ellis C, Greenspan A, Katz H, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicentre trial. J Am Acad Dermatol. 1996;34:482-5.

Smith EB, Padilla RS, McCabe JM, Becker LE. Benzoyl peroxide lotion (20%) in acne. Cutis. 1980;25:90-2.

Lucky A, Jorizzo JL, Rodriguez D, Jones TM, Stewart DM, Tschen EH. Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris. Cutis. 2001;68:34-40.

Baker M, Tuley M, Busdiecker FL, Herndon JH, Slayton RM. Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting. Cutis. 2001;68:41-7.